Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy

[Display omitted] •siRNA nanovehicles were micronized using supercritical CO2-assisted spray drying.•The siRNA integrity was preserved through the micronization process.•The ultrafine dry powders showed aerodynamic diameters of 3.5 μm and FPF above 40%•The micronized siRNA powders achieved 90% of si...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 591; p. 119989
Main Authors Silva, A. Sofia, Shopsowitz, Kevin E., Correa, Santiago, Morton, Stephen W., Dreaden, Erik C., Casimiro, Teresa, Aguiar-Ricardo, Ana, Hammond, Paula T.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] •siRNA nanovehicles were micronized using supercritical CO2-assisted spray drying.•The siRNA integrity was preserved through the micronization process.•The ultrafine dry powders showed aerodynamic diameters of 3.5 μm and FPF above 40%•The micronized siRNA powders achieved 90% of silencing for the mutant KRAS gene.•Alveolar in vivo biodistribution was achieved in healthy mice following inhalation. Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery have been found to be effective for efficient targeting to the liver, achieving high accumulations selectively in other organs, including lung tissues, can be a challenge. We demonstrate the rational design and engineering of a layer-by-layer (LbL) nanoparticle-containing aerosol that is able to achieve efficient, multistage delivery of siRNA in vitro. For the purpose, LbL nanoparticles were, for the first time, encapsulated in composite porous micro scale particles using a supercritical CO2-assisted spray drying (SASD) apparatus using chitosan as an excipient. Such particles exhibited aerodynamic properties highly favorable for pulmonary administration, and effective silencing of mutant KRAS in lung cancer cells derived from tumors of a non-small cell lung cancer (NSCLC) autochthonous model. Furthermore, efficient alveolar accumulation following inhalation in healthy mice was also observed, corroborating in vitro aerodynamic results, and opening new perspectives for further studies of effective lung therapies These results show that multistage aerosols assembled by supercritical CO2-assisted spray drying can enable efficient RNA interference therapy of pulmonary diseases including lung cancer.
AbstractList Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery have been found to be effective for efficient targeting to the liver, achieving high accumulations selectively in other organs, including lung tissues, can be a challenge. We demonstrate the rational design and engineering of a layer-by-layer (LbL) nanoparticle-containing aerosol that is able to achieve efficient, multistage delivery of siRNA in vitro. For the purpose, LbL nanoparticles were, for the first time, encapsulated in composite porous micro scale particles using a supercritical CO2-assisted spray drying (SASD) apparatus using chitosan as an excipient. Such particles exhibited aerodynamic properties highly favorable for pulmonary administration, and effective silencing of mutant KRAS in lung cancer cells derived from tumors of a non-small cell lung cancer (NSCLC) autochthonous model. Furthermore, efficient alveolar accumulation following inhalation in healthy mice was also observed, corroborating in vitro aerodynamic results, and opening new perspectives for further studies of effective lung therapies These results show that multistage aerosols assembled by supercritical CO -assisted spray drying can enable efficient RNA interference therapy of pulmonary diseases including lung cancer.
Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery have been found to be effective for efficient targeting to the liver, achieving high accumulations selectively in other organs, including lung tissues, can be a challenge. We demonstrate the rational design and engineering of a layer-by-layer (LbL) nanoparticle-containing aerosol that is able to achieve efficient, multistage delivery of siRNA in vitro . For the purpose, LbL nanoparticles were, for the first time, encapsulated in composite porous micro scale particles using a supercritical CO2-assisted spray drying (SASD) apparatus using chitosan as an excipient. Such particles exhibited aerodynamic properties highly favorable for pulmonary administration, and effective silencing of mutant KRAS in lung cancer cells derived from tumors of a non-small cell lung cancer (NSCLC) autochthonous model. Furthermore, efficient alveolar accumulation following inhalation in healthy mice was also observed, corroborating in vitro aerodynamic results, and opening new perspectives for further studies of effective lung therapies These results show that multistage aerosols assembled by supercritical CO 2 -assisted spray drying can enable efficient RNA interference therapy of pulmonary diseases including lung cancer.
[Display omitted] •siRNA nanovehicles were micronized using supercritical CO2-assisted spray drying.•The siRNA integrity was preserved through the micronization process.•The ultrafine dry powders showed aerodynamic diameters of 3.5 μm and FPF above 40%•The micronized siRNA powders achieved 90% of silencing for the mutant KRAS gene.•Alveolar in vivo biodistribution was achieved in healthy mice following inhalation. Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery have been found to be effective for efficient targeting to the liver, achieving high accumulations selectively in other organs, including lung tissues, can be a challenge. We demonstrate the rational design and engineering of a layer-by-layer (LbL) nanoparticle-containing aerosol that is able to achieve efficient, multistage delivery of siRNA in vitro. For the purpose, LbL nanoparticles were, for the first time, encapsulated in composite porous micro scale particles using a supercritical CO2-assisted spray drying (SASD) apparatus using chitosan as an excipient. Such particles exhibited aerodynamic properties highly favorable for pulmonary administration, and effective silencing of mutant KRAS in lung cancer cells derived from tumors of a non-small cell lung cancer (NSCLC) autochthonous model. Furthermore, efficient alveolar accumulation following inhalation in healthy mice was also observed, corroborating in vitro aerodynamic results, and opening new perspectives for further studies of effective lung therapies These results show that multistage aerosols assembled by supercritical CO2-assisted spray drying can enable efficient RNA interference therapy of pulmonary diseases including lung cancer.
ArticleNumber 119989
Author Silva, A. Sofia
Morton, Stephen W.
Casimiro, Teresa
Aguiar-Ricardo, Ana
Shopsowitz, Kevin E.
Dreaden, Erik C.
Correa, Santiago
Hammond, Paula T.
AuthorAffiliation d Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, United States
b Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
c Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
a LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
AuthorAffiliation_xml – name: a LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
– name: b Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
– name: c Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
– name: d Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, United States
Author_xml – sequence: 1
  givenname: A. Sofia
  surname: Silva
  fullname: Silva, A. Sofia
  email: sofiamsilva@ua.pt
  organization: LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
– sequence: 2
  givenname: Kevin E.
  surname: Shopsowitz
  fullname: Shopsowitz, Kevin E.
  organization: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, United States
– sequence: 3
  givenname: Santiago
  surname: Correa
  fullname: Correa, Santiago
  organization: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, United States
– sequence: 4
  givenname: Stephen W.
  surname: Morton
  fullname: Morton, Stephen W.
  organization: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, United States
– sequence: 5
  givenname: Erik C.
  surname: Dreaden
  fullname: Dreaden, Erik C.
  organization: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, United States
– sequence: 6
  givenname: Teresa
  surname: Casimiro
  fullname: Casimiro, Teresa
  organization: LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
– sequence: 7
  givenname: Ana
  surname: Aguiar-Ricardo
  fullname: Aguiar-Ricardo, Ana
  email: air@fct.unl.pt
  organization: LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
– sequence: 8
  givenname: Paula T.
  surname: Hammond
  fullname: Hammond, Paula T.
  email: hammond@mit.edu
  organization: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33122113$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1v1DAUtFAR3RZ-AihHLln8bMdOLqCqKh9SBVIFJw6WN37Z9cqJg-2s1H-PV7tUcOL0pPdm5o1mrsjFFCYk5DXQNVCQ7_Zrt593Jo5rRlnZQde13TOyglbxmgslL8iKctXWDSh-Sa5S2lNKJQP-glxyDowB8BX5-WCyC5PxlcXktlMVhmpcfHYpmy1WNi7bcvHugPGxOuDO9R5TNYRYzYsfC7GsH77eVG7KGAeMOPVY5R1GMz--JM8H4xO-Os9r8uPj3ffbz_X9t09fbm_u615IlWsp5dAaqzohWqm6jhd3HUAjDJeoGHYC6IZyIWBgVChrN5bahikKokHWN_yavD_pzstmRNvjlKPxeo5uLPZ0ME7_e5ncTm_DQatO0YbyIvD2LBDDrwVT1qNLPXpvJgxL0kw0UgAAFQXanKB9DClFHJ7eANXHYvRen4vRx2L0qZjCe_O3xyfWnyYK4MMJgCWpg8OoU--OaVoXsc_aBvefF78BZXWkPA
CitedBy_id crossref_primary_10_1016_j_cej_2023_147688
crossref_primary_10_1016_j_supflu_2022_105645
crossref_primary_10_1021_acs_molpharmaceut_1c00491
crossref_primary_10_1016_j_ijpharm_2021_121432
crossref_primary_10_3390_mi13091449
crossref_primary_10_1186_s43556_023_00160_0
crossref_primary_10_3390_molecules26247653
Cites_doi 10.1021/nn4047925
10.1016/j.jconrel.2013.03.026
10.1016/j.ijpharm.2010.05.032
10.1016/j.biomaterials.2009.09.030
10.1016/j.cocis.2013.06.002
10.1016/0095-8522(66)90004-3
10.1073/pnas.1412686111
10.14356/kona.2017005
10.2147/IJN.S169399
10.1016/j.ijpharm.2017.01.032
10.1016/j.addr.2009.09.004
10.1038/nrc3110
10.1016/j.ejpb.2014.09.002
10.1016/j.nantod.2015.06.008
10.1021/nn502861t
10.1016/j.jconrel.2018.04.003
10.1248/bpb.b13-00167
10.1016/j.supflu.2011.10.015
10.1016/j.jconrel.2015.09.004
10.1002/ppsc.201600123
10.1016/j.addr.2011.02.006
10.1016/j.jconrel.2016.01.040
10.1016/j.ejpb.2017.08.001
10.1016/j.ijpharm.2009.05.046
10.1016/j.addr.2014.05.018
10.1002/smll.201501034
10.1021/ja3116873
10.3390/ma10010074
10.1007/s11095-014-1589-7
10.1158/1078-0432.CCR-16-2186
10.1016/j.supflu.2017.06.004
10.1039/C5RA21934E
10.1016/j.supflu.2016.04.001
10.1002/smll.200400093
10.1073/pnas.1708391114
10.1021/acs.jced.7b00820
10.1016/j.biomaterials.2005.05.028
10.1016/j.ijpharm.2013.07.024
10.1016/0168-3659(87)90034-4
10.1002/mabi.200400092
10.1016/j.jconrel.2011.08.008
10.5772/57235
10.3109/1061186X.2011.622404
10.1016/j.ijpharm.2008.09.004
10.1016/j.ejpb.2007.05.007
10.1016/j.ijpharm.2017.07.013
10.1007/s11051-014-2602-0
10.1039/C4EE01647E
10.1016/j.biomaterials.2013.05.071
10.1002/adfm.201504385
10.1039/C2CS15261D
10.1002/smll.201401284
10.1016/S1773-2247(10)50004-2
10.4155/tde.15.8
10.1080/10717544.2017.1321058
10.1038/nrd.2018.20
10.1039/C5NR09112H
10.1007/s11095-007-9475-1
10.1208/s12249-009-9290-6
ContentType Journal Article
Copyright 2020 Elsevier B.V.
Copyright © 2020 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2020 Elsevier B.V.
– notice: Copyright © 2020 Elsevier B.V. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.ijpharm.2020.119989
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3476
EndPage 119989
ExternalDocumentID 10_1016_j_ijpharm_2020_119989
33122113
S0378517320309741
Genre Journal Article
GrantInformation_xml – fundername: NIBIB NIH HHS
  grantid: F32 EB017614
– fundername: NCI NIH HHS
  grantid: P30 CA014051
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSP
SSZ
T5K
TEORI
~02
~G-
AAQFI
AAXKI
AKRWK
NPM
RIG
.GJ
29J
3O-
53G
5VS
AAQXK
AAYXX
ABXDB
ACRPL
ADMUD
ADNMO
AFJKZ
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
R2-
SEW
SPT
WUQ
ZXP
7X8
5PM
ID FETCH-LOGICAL-c467t-666f8ad794486799333191154a36e72e9410b03441f2047ddbd0d5270145e2c53
IEDL.DBID AIKHN
ISSN 0378-5173
IngestDate Tue Sep 17 20:39:58 EDT 2024
Tue Dec 03 23:38:16 EST 2024
Fri Dec 06 02:11:34 EST 2024
Sat Sep 28 08:23:39 EDT 2024
Fri Feb 23 02:42:01 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Small interfering RNAs
Supercritical carbon dioxide
Layer-by-layer nanoparticles
Micronized systems
Pulmonary delivery
Language English
License Copyright © 2020 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c467t-666f8ad794486799333191154a36e72e9410b03441f2047ddbd0d5270145e2c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current affiliation: Faculty of Medicine, University of British Columbia, BC V1Y 1T3, Canada
Current affiliation: Department of Materials Science and Engineering, Stanford University, 496 Lomita Mall, Stanford, CA 94305, USA
Current affiliation: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30332, United States. Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, 30332, United States.
Current affiliation: CICECO, Department of Chemistry, University of Aveiro, 3810193, Aveiro, Portugal
OpenAccessLink http://manuscript.elsevier.com/S0378517320309741/pdf/S0378517320309741.pdf
PMID 33122113
PQID 2456411104
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7970503
proquest_miscellaneous_2456411104
crossref_primary_10_1016_j_ijpharm_2020_119989
pubmed_primary_33122113
elsevier_sciencedirect_doi_10_1016_j_ijpharm_2020_119989
PublicationCentury 2000
PublicationDate 2020-12-15
PublicationDateYYYYMMDD 2020-12-15
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-12-15
  day: 15
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of pharmaceutics
PublicationTitleAlternate Int J Pharm
PublicationYear 2020
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Xu, Tian, Sun, Jiao, Zhang, Chen (b0300) 2015; 5
Silva, Sousa, Cabral, Silva, Costa, Miguel, Bonifácio, Casimiro, Correia, Aguiar-Ricardo (b0250) 2017; 519
Amidi, M., Pellikaan, H.C., de Boer, A.H., Crommelin, D.J. a, Hennink, W.E., Jiskoot, W., 2008. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur. J. Pharm. Biopharm. 68, 191–200. https://doi.org/10.1016/j.ejpb.2007.05.007.
Zeng, Chen, Liang, Xu, Jing (b0335) 2004; 4
Costa, Casimiro, Aguiar-Ricardo (b0075) 2018; 63
Moreira, Gaspar, Costa, de Melo-Diogo, Machado, Paquete, Correia (b0180) 2014; 88
Cabral, Sousa, Silva, Paninho, Temtem, Costa, Casimiro, Aguiar-Ricardo (b0030) 2016; 116
Xue, Dahlman, Tammela, Khan, Sood, Dave, Cai, Chirino, Yang, Bronson, Crowley, Sahay, Schroeder, Langer, Anderson, Jacks (b0315) 2014; 24
Morrison (b0185) 2018; 17
Youngren-ortiz, Gandhi, Mahavir, Street, Program, Cancer (b0325) 2017; 34
Domínguez-delgado, C.L., Rodríguez-cruz, I.M., Fuentes-prado, E., Escobar-chávez, J.J., Vidal-romero, G., García-gonzález, L., Puente-lee, R.I., 2014. Drug Carrier Systems Using Chitosan for Non Parenteral Routes, in: Gowder, S.J.T. (Ed.), Pharmacology and Therapeutics. InTech, pp. 273–275.
El-Sherbiny, Smyth (b0110) 2010; 395
Xue, Dahlman, Tammela, Khan, Sood, Dave, Cai, Chirino, Yang, Bronson, Crowley, Sahay, Schroeder, Langer, Anderson, Jacks (b0320) 2014; 111
Xu, Kankala, Pan, Yuan, Wang, Chen (b0310) 2018; 13
Okuda, Morishita, Mizutani, Shibayama, Okazaki, Okamoto (b0205) 2018; 279
Ortiz, Jornada, Pohlmann, Guterres (b0210) 2015; 16
De Backer, Cerrada, Pérez-Gil, De Smedt, Raemdonck (b0085) 2015; 220
Yue, Liu, Zheng, Zhao, Wang, Ma, Cai (b0330) 2013; 34
FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease [WWW Document], 2018. URL https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm616518.htm (accessed 10.22.18).
Sharma, Somavarapu, Colombani, Govind, Taylor (b0240) 2013; 455
Ritger, P.L., Peppas, N. a., 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5, 23–36. https://doi.org/10.1016/0168-3659(87)90034-4.
Grenha, Al-Qadi, Seijo, Remuñán-López (b0125) 2010; 20
Hartmann, Hossfeld, Schlosshauer, Mittnacht, Pêgo, Dauner, Doser, Stoll, Krastev (b0135) 2013; 168
Silva, Tavares, Aguiar-Ricardo (b0255) 2014; 16
Moura, Neves, Costa (b0190) 2014; 53
Dufort, Bianchi, Henry, Lux, Le Duc, Josserand, Louis, Perriat, Crémillieux, Tillement, Coll (b0105) 2015; 11
Lam, Liang, Chan (b0160) 2012; 64
Naikwade, Bajaj, Gurav, Gatne, Singh Soni (b0195) 2009; 10
Agnoletti, Bohr, Thanki, Wan, Zeng, Boetker, Yang, Foged (b0005) 2017; 120
Dreaden, Morton, Shopsowitz, Choi, Deng (b0100) 2015; 8
Correa, Dreaden, Gu, Hammond (b0070) 2015; 240
Wang, Huang, Yang, Zhang, Wu, Gao, Wang, O’Hare, Zhong (b0290) 2014; 7
Webb, Chimenti, Jacobson, Barber (b0295) 2011; 11
The top 10 causes of death [WWW Document], 2018. URL http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed 10.15.18).
Jere, Jiang, Kim, Arote, Choi, Yun, Cho, Cho (b0145) 2009; 378
Chow, Qiu, Lo, Lin, Chan, Kwok, Lam (b0045) 2017; 530
Restani, Silva, Pires, Cabral, Correia, Casimiro, Bonifácio, Aguiar-Ricardo (b0225) 2016; 33
Krieg, Hirsch, Scholz, Nuhn, Tabujew, Bauer, Decker, Khobta, Schmidt, Tremel, Zentel, Peneva, Koynov, Mason, Helm (b0155) 2014; 32
Silva, Silva, Fernandez-Lodeiro, Casimiro, Lodeiro, Aguiar-Ricardo (b0260) 2017; 10
Aguiar-Ricardo, Costa (b0010) 2019
Correa, Choi, Dreaden, Renggli, Shi, Gu, Shopsowitz, Quadir, Ben-Akiva, Hammond (b0065) 2016; 26
Maggini, Cabrera, Ruiz-Carretero, Prasetyanto, Robinet, De Cola (b0165) 2016; 8
Malmsten (b0170) 2013; 18
Al-Qadi, Grenha, Carrión Recio, Seijo, Remuñán-López (b0015) 2012; 157
Connor, Mwamuka, Gole, Murphy, Wyatt (b0060) 2005; 1
Deng, Morton, Ben-akiva, Dreaden, Shopsowitz, Hammond (b0090) 2013; 7
Gu, Deng, Roy, Hammond (b0130) 2017; 23
Qu, Zhao, Zhu, Wang, Dai, Guo, Qu, Zhao, Zhu, Wang, Dai, Guo, Hao (b0220) 2017; 24
Feldmann, Merkel (b0120) 2015; 6
Conde, Ambrosone, Hernandez, Tian, McCully, Berry, Baptista, Tortiglione, de la Fuente (b0055) 2015; 10
Chung, Daemen, Cheng, Long, Cooper, Wang, Tran, Singh, Gnad, Modrusan, Foreman, Junttila (b0050) 2017; 114
Caruso, Hyeon, Rotello, Lee, Koo, Sun, Ryu, Kim, Kwon (b0035) 2012; 41
Kean, Thanou (b0150) 2010; 62
Pai, Jain, Bannalikar, Menon (b0215) 2015; 28
Okuda, Kito, Oiwa, Fukushima, Hira, Okamoto (b0200) 2013; 36
Bering, Dubinin, Serpinsky (b0025) 1966; 21
Zhang, Xu, Jiang, Calin, Lam, Zhang (b0340) 2013; 135
Temtem, Barroso, Casimiro, Mano, Aguiar-Ricardo (b0275) 2012; 66
Council of Europe (b0080) 2010
Siepmann, Siepmann (b0245) 2008; 364
Tavares, Cabral, Costa, Martins, Fernandes, Casimiro, Aguiar-Ricardo (b0270) 2017; 128
Choi, Chung, Min, Yoon, Kim, Park, Kwon, Jeong (b0040) 2010; 31
Rouquerol, Rouquerol, Sing (b0235) 1999
Jae, Kwon, Lee, Chung, Kim, Kim, Park, Kim, Sang, Kwon, Seo (b0140) 2006; 27
Merkel, Rubinstein, Kissel (b0175) 2014; 75
Taratula, Garbuzenko, Chen, Minko (b0265) 2011; 19
Xu, Wang, Zhang, Tian, Park, Chen (b0305) 2015; 11
Vehring (b0285) 2008; 25
Dreaden (10.1016/j.ijpharm.2020.119989_b0100) 2015; 8
Deng (10.1016/j.ijpharm.2020.119989_b0090) 2013; 7
Merkel (10.1016/j.ijpharm.2020.119989_b0175) 2014; 75
Krieg (10.1016/j.ijpharm.2020.119989_b0155) 2014; 32
Morrison (10.1016/j.ijpharm.2020.119989_b0185) 2018; 17
Xue (10.1016/j.ijpharm.2020.119989_b0320) 2014; 111
Jere (10.1016/j.ijpharm.2020.119989_b0145) 2009; 378
Siepmann (10.1016/j.ijpharm.2020.119989_b0245) 2008; 364
Temtem (10.1016/j.ijpharm.2020.119989_b0275) 2012; 66
Silva (10.1016/j.ijpharm.2020.119989_b0255) 2014; 16
Grenha (10.1016/j.ijpharm.2020.119989_b0125) 2010; 20
Webb (10.1016/j.ijpharm.2020.119989_b0295) 2011; 11
Yue (10.1016/j.ijpharm.2020.119989_b0330) 2013; 34
Conde (10.1016/j.ijpharm.2020.119989_b0055) 2015; 10
10.1016/j.ijpharm.2020.119989_b0280
Bering (10.1016/j.ijpharm.2020.119989_b0025) 1966; 21
Zeng (10.1016/j.ijpharm.2020.119989_b0335) 2004; 4
Xu (10.1016/j.ijpharm.2020.119989_b0310) 2018; 13
Restani (10.1016/j.ijpharm.2020.119989_b0225) 2016; 33
Okuda (10.1016/j.ijpharm.2020.119989_b0205) 2018; 279
Silva (10.1016/j.ijpharm.2020.119989_b0260) 2017; 10
Jae (10.1016/j.ijpharm.2020.119989_b0140) 2006; 27
Dufort (10.1016/j.ijpharm.2020.119989_b0105) 2015; 11
Xu (10.1016/j.ijpharm.2020.119989_b0305) 2015; 11
Tavares (10.1016/j.ijpharm.2020.119989_b0270) 2017; 128
10.1016/j.ijpharm.2020.119989_b0115
Vehring (10.1016/j.ijpharm.2020.119989_b0285) 2008; 25
Moura (10.1016/j.ijpharm.2020.119989_b0190) 2014; 53
10.1016/j.ijpharm.2020.119989_b0230
Youngren-ortiz (10.1016/j.ijpharm.2020.119989_b0325) 2017; 34
Cabral (10.1016/j.ijpharm.2020.119989_b0030) 2016; 116
Maggini (10.1016/j.ijpharm.2020.119989_b0165) 2016; 8
Kean (10.1016/j.ijpharm.2020.119989_b0150) 2010; 62
Malmsten (10.1016/j.ijpharm.2020.119989_b0170) 2013; 18
Zhang (10.1016/j.ijpharm.2020.119989_b0340) 2013; 135
Silva (10.1016/j.ijpharm.2020.119989_b0250) 2017; 519
El-Sherbiny (10.1016/j.ijpharm.2020.119989_b0110) 2010; 395
Gu (10.1016/j.ijpharm.2020.119989_b0130) 2017; 23
Rouquerol (10.1016/j.ijpharm.2020.119989_b0235) 1999
Agnoletti (10.1016/j.ijpharm.2020.119989_b0005) 2017; 120
Al-Qadi (10.1016/j.ijpharm.2020.119989_b0015) 2012; 157
Hartmann (10.1016/j.ijpharm.2020.119989_b0135) 2013; 168
Ortiz (10.1016/j.ijpharm.2020.119989_b0210) 2015; 16
Correa (10.1016/j.ijpharm.2020.119989_b0070) 2015; 240
Moreira (10.1016/j.ijpharm.2020.119989_b0180) 2014; 88
Qu (10.1016/j.ijpharm.2020.119989_b0220) 2017; 24
Taratula (10.1016/j.ijpharm.2020.119989_b0265) 2011; 19
Chung (10.1016/j.ijpharm.2020.119989_b0050) 2017; 114
Feldmann (10.1016/j.ijpharm.2020.119989_b0120) 2015; 6
De Backer (10.1016/j.ijpharm.2020.119989_b0085) 2015; 220
Chow (10.1016/j.ijpharm.2020.119989_b0045) 2017; 530
Naikwade (10.1016/j.ijpharm.2020.119989_b0195) 2009; 10
10.1016/j.ijpharm.2020.119989_b0020
Council of Europe (10.1016/j.ijpharm.2020.119989_b0080) 2010
Lam (10.1016/j.ijpharm.2020.119989_b0160) 2012; 64
Choi (10.1016/j.ijpharm.2020.119989_b0040) 2010; 31
Xue (10.1016/j.ijpharm.2020.119989_b0315) 2014; 24
Wang (10.1016/j.ijpharm.2020.119989_b0290) 2014; 7
Caruso (10.1016/j.ijpharm.2020.119989_b0035) 2012; 41
Costa (10.1016/j.ijpharm.2020.119989_b0075) 2018; 63
Correa (10.1016/j.ijpharm.2020.119989_b0065) 2016; 26
10.1016/j.ijpharm.2020.119989_b0095
Okuda (10.1016/j.ijpharm.2020.119989_b0200) 2013; 36
Pai (10.1016/j.ijpharm.2020.119989_b0215) 2015; 28
Sharma (10.1016/j.ijpharm.2020.119989_b0240) 2013; 455
Xu (10.1016/j.ijpharm.2020.119989_b0300) 2015; 5
Aguiar-Ricardo (10.1016/j.ijpharm.2020.119989_b0010) 2019
Connor (10.1016/j.ijpharm.2020.119989_b0060) 2005; 1
References_xml – volume: 21
  start-page: 378
  year: 1966
  end-page: 393
  ident: b0025
  article-title: Theory of volume filling for vapor adsorption
  publication-title: J. Colloid Interface Sci.
  contributor:
    fullname: Serpinsky
– volume: 64
  start-page: 1
  year: 2012
  end-page: 15
  ident: b0160
  article-title: Pulmonary delivery of therapeutic siRNA
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Chan
– volume: 10
  start-page: 74
  year: 2017
  end-page: 89
  ident: b0260
  article-title: Supercritical CO2-assisted spray drying of strawberry-like gold-coated magnetite nanocomposites in chitosan powders for inhalation
  publication-title: Materials (Basel).
  contributor:
    fullname: Aguiar-Ricardo
– volume: 530
  start-page: 40
  year: 2017
  end-page: 52
  ident: b0045
  article-title: Inhaled powder formulation of naked siRNA using spray drying technology with L-leucine as dispersion enhancer
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Lam
– volume: 11
  start-page: 215
  year: 2015
  end-page: 221
  ident: b0105
  article-title: Nebulized Gadolinium-Based Nanoparticles: A Theranostic Approach for Lung Tumor Imaging and Radiosensitization
  publication-title: Small
  contributor:
    fullname: Coll
– volume: 18
  start-page: 468
  year: 2013
  end-page: 480
  ident: b0170
  article-title: Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA
  publication-title: Curr. Opin. Colloid Interface Sci.
  contributor:
    fullname: Malmsten
– volume: 34
  start-page: 6853
  year: 2013
  end-page: 6861
  ident: b0330
  article-title: IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy
  publication-title: Biomaterials
  contributor:
    fullname: Cai
– volume: 220
  start-page: 642
  year: 2015
  end-page: 650
  ident: b0085
  article-title: Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy
  publication-title: J. Control. Release
  contributor:
    fullname: Raemdonck
– volume: 1
  start-page: 325
  year: 2005
  end-page: 327
  ident: b0060
  article-title: Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity
  publication-title: Small
  contributor:
    fullname: Wyatt
– volume: 25
  start-page: 999
  year: 2008
  end-page: 1022
  ident: b0285
  article-title: Pharmaceutical particle engineering via spray drying
  publication-title: Pharm. Res.
  contributor:
    fullname: Vehring
– year: 2019
  ident: b0010
  article-title: Supercritical Fluid Manufacture
  publication-title: Pharmaceutical Inhalation Aerosol Technology
  contributor:
    fullname: Costa
– volume: 240
  start-page: 364
  year: 2015
  end-page: 386
  ident: b0070
  article-title: Engineering nanolayered particles for modular drug delivery
  publication-title: J. Control. Release
  contributor:
    fullname: Hammond
– volume: 395
  start-page: 132
  year: 2010
  end-page: 141
  ident: b0110
  article-title: Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Smyth
– volume: 75
  start-page: 112
  year: 2014
  end-page: 128
  ident: b0175
  article-title: siRNA Delivery to the lung: What’s new?
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Kissel
– volume: 63
  start-page: 885
  year: 2018
  end-page: 896
  ident: b0075
  article-title: Optimization of Supercritical CO 2 -Assisted Atomization: Phase Behavior and Design of Experiments
  publication-title: J. Chem. Eng. Data
  contributor:
    fullname: Aguiar-Ricardo
– volume: 116
  start-page: 26
  year: 2016
  end-page: 35
  ident: b0030
  article-title: Design of experiments approach on the preparation of dry inhaler chitosan composite formulations by supercritical CO 2 -assisted
  publication-title: J. Supercrit. Fluids
  contributor:
    fullname: Aguiar-Ricardo
– volume: 364
  start-page: 328
  year: 2008
  end-page: 343
  ident: b0245
  article-title: Mathematical modeling of drug delivery
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Siepmann
– volume: 10
  start-page: 421
  year: 2015
  end-page: 450
  ident: b0055
  article-title: 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  publication-title: Nano Today
  contributor:
    fullname: de la Fuente
– volume: 7
  start-page: 3478
  year: 2014
  end-page: 3518
  ident: b0290
  article-title: Recent advances in solid sorbents for CO
  publication-title: Energy Environ. Sci.
  contributor:
    fullname: Zhong
– volume: 16
  start-page: 2602
  year: 2014
  end-page: 2619
  ident: b0255
  article-title: Sustainable strategies for nano-in-micro particle engineering for pulmonary delivery
  publication-title: J. Nanoparticle Res.
  contributor:
    fullname: Aguiar-Ricardo
– volume: 378
  start-page: 194
  year: 2009
  end-page: 200
  ident: b0145
  article-title: Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Cho
– volume: 157
  start-page: 383
  year: 2012
  end-page: 390
  ident: b0015
  article-title: Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations
  publication-title: J. Control. Release
  contributor:
    fullname: Remuñán-López
– volume: 27
  start-page: 119
  year: 2006
  end-page: 126
  ident: b0140
  article-title: Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity
  publication-title: Biomaterials
  contributor:
    fullname: Seo
– volume: 279
  start-page: 99
  year: 2018
  end-page: 113
  ident: b0205
  article-title: Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity
  publication-title: J. Control. Release
  contributor:
    fullname: Okamoto
– volume: 41
  start-page: 2656
  year: 2012
  end-page: 2672
  ident: b0035
  article-title: Nanomedicine themed issue Multifunctional nanoparticles for multimodal imaging and theragnosis w
  publication-title: Chem. Soc. Rev.
  contributor:
    fullname: Kwon
– volume: 114
  start-page: E10947
  year: 2017
  end-page: E10955
  ident: b0050
  article-title: Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous
  publication-title: Proc. Natl. Acad. Sci.
  contributor:
    fullname: Junttila
– volume: 31
  start-page: 106
  year: 2010
  end-page: 114
  ident: b0040
  article-title: Self-assembled hyaluronic acid nanoparticles for active tumor targeting
  publication-title: Biomaterials
  contributor:
    fullname: Jeong
– volume: 6
  start-page: 1239
  year: 2015
  end-page: 1241
  ident: b0120
  article-title: The advantages of pulmonary delivery of therapeutic siRNA
  publication-title: Ther. Deliv.
  contributor:
    fullname: Merkel
– volume: 28
  start-page: 1
  year: 2015
  end-page: 17
  ident: b0215
  article-title: Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler
  publication-title: J. Aerosol Med. Pulm. Drug Deliv.
  contributor:
    fullname: Menon
– volume: 111
  start-page: 3553
  year: 2014
  end-page: 3561
  ident: b0320
  article-title: Small RNA combination therapy for lung cancer
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Jacks
– volume: 62
  start-page: 3
  year: 2010
  end-page: 11
  ident: b0150
  article-title: Biodegradation, biodistribution and toxicity of chitosan
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Thanou
– volume: 519
  start-page: 240
  year: 2017
  end-page: 249
  ident: b0250
  article-title: Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Aguiar-Ricardo
– volume: 120
  start-page: 9
  year: 2017
  end-page: 21
  ident: b0005
  article-title: Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Foged
– volume: 16
  start-page: 18
  year: 2015
  end-page: 20
  ident: b0210
  article-title: Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone : Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation
  publication-title: J. Aerosol Med. Pulm. Drug Deliv.
  contributor:
    fullname: Guterres
– volume: 17
  start-page: 156
  year: 2018
  end-page: 157
  ident: b0185
  article-title: Alnylam prepares to land first RNAi drug approval
  publication-title: Nat. Rev. Drug Discov.
  contributor:
    fullname: Morrison
– volume: 19
  start-page: 900
  year: 2011
  end-page: 914
  ident: b0265
  article-title: Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
  publication-title: J. Drug Target.
  contributor:
    fullname: Minko
– volume: 10
  start-page: 993
  year: 2009
  end-page: 1012
  ident: b0195
  article-title: Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study
  publication-title: AAPS PharmSciTech
  contributor:
    fullname: Singh Soni
– volume: 36
  start-page: 1183
  year: 2013
  end-page: 1191
  ident: b0200
  article-title: Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique
  publication-title: Biol. Pharm. Bull.
  contributor:
    fullname: Okamoto
– volume: 455
  start-page: 241
  year: 2013
  end-page: 247
  ident: b0240
  article-title: Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Taylor
– volume: 5
  start-page: 103380
  year: 2015
  end-page: 103385
  ident: b0300
  article-title: A pH sensitive co-delivery system of siRNA and doxorubicin for pulmonary administration to B16F10 metastatic lung cancer
  publication-title: RSC Adv.
  contributor:
    fullname: Chen
– volume: 11
  start-page: 4321
  year: 2015
  end-page: 4333
  ident: b0305
  article-title: Pulmonary codelivery of doxorubicin and siRNA by pH-Sensitive nanoparticles for therapy of metastatic lung cancer
  publication-title: Small
  contributor:
    fullname: Chen
– volume: 33
  start-page: 851
  year: 2016
  end-page: 858
  ident: b0225
  article-title: Nano-in-Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery
  publication-title: Part. Part. Syst. Charact.
  contributor:
    fullname: Aguiar-Ricardo
– volume: 168
  start-page: 289
  year: 2013
  end-page: 297
  ident: b0135
  article-title: Hyaluronic acid / chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes
  publication-title: J. Control. Release
  contributor:
    fullname: Krastev
– volume: 24
  start-page: E3553
  year: 2014
  end-page: E3561
  ident: b0315
  article-title: Small RNA combination therapy for lung cancer
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  contributor:
    fullname: Jacks
– volume: 53
  start-page: 16
  year: 2014
  end-page: 23
  ident: b0190
  article-title: Design of Composite Particles via Spray Drying for DPI Formulations
  publication-title: ONdrugDelivery
  contributor:
    fullname: Costa
– volume: 88
  start-page: 1012
  year: 2014
  end-page: 1025
  ident: b0180
  article-title: Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Correia
– volume: 20
  start-page: 33
  year: 2010
  end-page: 43
  ident: b0125
  article-title: The potential of chitosan for pulmonary drug delivery
  publication-title: J. Drug Deliv. Sci. Technol.
  contributor:
    fullname: Remuñán-López
– volume: 8
  start-page: 8374
  year: 2015
  end-page: 8382
  ident: b0100
  article-title: Bimodal Tumor-Targeting from Microenvironment Responsive
  publication-title: ACS Nano
  contributor:
    fullname: Deng
– volume: 23
  start-page: 7312
  year: 2017
  end-page: 7323
  ident: b0130
  article-title: A combination RNAi-chemotherapy layer-by-layer nanoparticle for systemic targeting of KRAS/P53 with cisplatin to treat non–small cell lung cancer
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Hammond
– start-page: 93
  year: 1999
  end-page: 115
  ident: b0235
  article-title: Interpretation of Physisorption Isotherms at the Gas-Solid Interface
  publication-title: Adsorption by Powders and Porous Solids
  contributor:
    fullname: Sing
– volume: 135
  start-page: 2427
  year: 2013
  end-page: 2430
  ident: b0340
  article-title: Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure
  publication-title: J. Am. Chem. Soc.
  contributor:
    fullname: Zhang
– volume: 11
  start-page: 671
  year: 2011
  end-page: 677
  ident: b0295
  article-title: Dysregulated pH: A perfect storm for cancer progression
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Barber
– volume: 13
  start-page: 4685
  year: 2018
  end-page: 4698
  ident: b0310
  article-title: Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology
  publication-title: Int. J. Nanomedicine
  contributor:
    fullname: Chen
– volume: 4
  start-page: 1118
  year: 2004
  end-page: 1125
  ident: b0335
  article-title: Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers
  publication-title: Macromol. Biosci.
  contributor:
    fullname: Jing
– start-page: 274
  year: 2010
  end-page: 285
  ident: b0080
  article-title: Preparations for Inhalation: Aerodynaminc Assessment of Fine Particles
  publication-title: Eur. Pharm.
  contributor:
    fullname: Council of Europe
– volume: 8
  start-page: 7240
  year: 2016
  end-page: 7247
  ident: b0165
  article-title: Breakable mesoporous silica nanoparticles for targeted drug delivery
  publication-title: Nanoscale
  contributor:
    fullname: De Cola
– volume: 26
  start-page: 991
  year: 2016
  end-page: 1003
  ident: b0065
  article-title: Highly Scalable, Closed-Loop Synthesis of Drug-Loaded, Layer-by-Layer Nanoparticles
  publication-title: Adv. Funct. Mater.
  contributor:
    fullname: Hammond
– volume: 32
  start-page: 1957
  year: 2014
  end-page: 1974
  ident: b0155
  article-title: New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes
  publication-title: Pharm. Res.
  contributor:
    fullname: Helm
– volume: 7
  start-page: 9571
  year: 2013
  end-page: 9584
  ident: b0090
  article-title: Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
  publication-title: ACS Nano
  contributor:
    fullname: Hammond
– volume: 24
  start-page: 745
  year: 2017
  end-page: 751
  ident: b0220
  article-title: Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting Preparation and testing of cefquinome-loaded poly lactic-co-glycolic
  publication-title: Drug Deliv.
  contributor:
    fullname: Hao
– volume: 66
  start-page: 398
  year: 2012
  end-page: 404
  ident: b0275
  article-title: Dual stimuli responsive poly(N-isopropylacrylamide) coated chitosan scaffolds for controlled release prepared from a non residue technology
  publication-title: J. Supercrit. Fluids
  contributor:
    fullname: Aguiar-Ricardo
– volume: 128
  start-page: 235
  year: 2017
  end-page: 243
  ident: b0270
  article-title: Development of PLGA dry powder microparticles by supercritical CO2-assisted spray-drying for potential vaccine delivery to the lungs
  publication-title: J. Supercrit. Fluids
  contributor:
    fullname: Aguiar-Ricardo
– volume: 34
  start-page: 44
  year: 2017
  end-page: 69
  ident: b0325
  article-title: Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrierbased Delivery Systems
  publication-title: KONA Powder Part. J.
  contributor:
    fullname: Cancer
– volume: 7
  start-page: 9571
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0090
  article-title: Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
  publication-title: ACS Nano
  doi: 10.1021/nn4047925
  contributor:
    fullname: Deng
– volume: 168
  start-page: 289
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0135
  article-title: Hyaluronic acid / chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2013.03.026
  contributor:
    fullname: Hartmann
– volume: 395
  start-page: 132
  year: 2010
  ident: 10.1016/j.ijpharm.2020.119989_b0110
  article-title: Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2010.05.032
  contributor:
    fullname: El-Sherbiny
– volume: 31
  start-page: 106
  year: 2010
  ident: 10.1016/j.ijpharm.2020.119989_b0040
  article-title: Self-assembled hyaluronic acid nanoparticles for active tumor targeting
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.09.030
  contributor:
    fullname: Choi
– volume: 18
  start-page: 468
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0170
  article-title: Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA
  publication-title: Curr. Opin. Colloid Interface Sci.
  doi: 10.1016/j.cocis.2013.06.002
  contributor:
    fullname: Malmsten
– volume: 21
  start-page: 378
  year: 1966
  ident: 10.1016/j.ijpharm.2020.119989_b0025
  article-title: Theory of volume filling for vapor adsorption
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/0095-8522(66)90004-3
  contributor:
    fullname: Bering
– volume: 111
  start-page: 3553
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0320
  article-title: Small RNA combination therapy for lung cancer
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1412686111
  contributor:
    fullname: Xue
– volume: 34
  start-page: 44
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0325
  article-title: Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrierbased Delivery Systems
  publication-title: KONA Powder Part. J.
  doi: 10.14356/kona.2017005
  contributor:
    fullname: Youngren-ortiz
– volume: 13
  start-page: 4685
  year: 2018
  ident: 10.1016/j.ijpharm.2020.119989_b0310
  article-title: Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S169399
  contributor:
    fullname: Xu
– volume: 519
  start-page: 240
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0250
  article-title: Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.01.032
  contributor:
    fullname: Silva
– volume: 62
  start-page: 3
  year: 2010
  ident: 10.1016/j.ijpharm.2020.119989_b0150
  article-title: Biodegradation, biodistribution and toxicity of chitosan
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2009.09.004
  contributor:
    fullname: Kean
– volume: 11
  start-page: 671
  year: 2011
  ident: 10.1016/j.ijpharm.2020.119989_b0295
  article-title: Dysregulated pH: A perfect storm for cancer progression
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3110
  contributor:
    fullname: Webb
– volume: 88
  start-page: 1012
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0180
  article-title: Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2014.09.002
  contributor:
    fullname: Moreira
– volume: 10
  start-page: 421
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0055
  article-title: 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2015.06.008
  contributor:
    fullname: Conde
– volume: 8
  start-page: 8374
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0100
  article-title: Bimodal Tumor-Targeting from Microenvironment Responsive
  publication-title: ACS Nano
  doi: 10.1021/nn502861t
  contributor:
    fullname: Dreaden
– ident: 10.1016/j.ijpharm.2020.119989_b0115
– volume: 279
  start-page: 99
  year: 2018
  ident: 10.1016/j.ijpharm.2020.119989_b0205
  article-title: Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2018.04.003
  contributor:
    fullname: Okuda
– volume: 36
  start-page: 1183
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0200
  article-title: Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.b13-00167
  contributor:
    fullname: Okuda
– volume: 66
  start-page: 398
  year: 2012
  ident: 10.1016/j.ijpharm.2020.119989_b0275
  article-title: Dual stimuli responsive poly(N-isopropylacrylamide) coated chitosan scaffolds for controlled release prepared from a non residue technology
  publication-title: J. Supercrit. Fluids
  doi: 10.1016/j.supflu.2011.10.015
  contributor:
    fullname: Temtem
– ident: 10.1016/j.ijpharm.2020.119989_b0280
– volume: 220
  start-page: 642
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0085
  article-title: Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2015.09.004
  contributor:
    fullname: De Backer
– volume: 33
  start-page: 851
  year: 2016
  ident: 10.1016/j.ijpharm.2020.119989_b0225
  article-title: Nano-in-Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery
  publication-title: Part. Part. Syst. Charact.
  doi: 10.1002/ppsc.201600123
  contributor:
    fullname: Restani
– volume: 64
  start-page: 1
  year: 2012
  ident: 10.1016/j.ijpharm.2020.119989_b0160
  article-title: Pulmonary delivery of therapeutic siRNA
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2011.02.006
  contributor:
    fullname: Lam
– volume: 240
  start-page: 364
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0070
  article-title: Engineering nanolayered particles for modular drug delivery
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2016.01.040
  contributor:
    fullname: Correa
– start-page: 93
  year: 1999
  ident: 10.1016/j.ijpharm.2020.119989_b0235
  article-title: Interpretation of Physisorption Isotherms at the Gas-Solid Interface
  contributor:
    fullname: Rouquerol
– volume: 24
  start-page: E3553
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0315
  article-title: Small RNA combination therapy for lung cancer
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  contributor:
    fullname: Xue
– volume: 120
  start-page: 9
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0005
  article-title: Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2017.08.001
  contributor:
    fullname: Agnoletti
– volume: 378
  start-page: 194
  year: 2009
  ident: 10.1016/j.ijpharm.2020.119989_b0145
  article-title: Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2009.05.046
  contributor:
    fullname: Jere
– volume: 75
  start-page: 112
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0175
  article-title: siRNA Delivery to the lung: What’s new?
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2014.05.018
  contributor:
    fullname: Merkel
– volume: 11
  start-page: 4321
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0305
  article-title: Pulmonary codelivery of doxorubicin and siRNA by pH-Sensitive nanoparticles for therapy of metastatic lung cancer
  publication-title: Small
  doi: 10.1002/smll.201501034
  contributor:
    fullname: Xu
– volume: 135
  start-page: 2427
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0340
  article-title: Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja3116873
  contributor:
    fullname: Zhang
– volume: 10
  start-page: 74
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0260
  article-title: Supercritical CO2-assisted spray drying of strawberry-like gold-coated magnetite nanocomposites in chitosan powders for inhalation
  publication-title: Materials (Basel).
  doi: 10.3390/ma10010074
  contributor:
    fullname: Silva
– volume: 32
  start-page: 1957
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0155
  article-title: New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-014-1589-7
  contributor:
    fullname: Krieg
– volume: 23
  start-page: 7312
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0130
  article-title: A combination RNAi-chemotherapy layer-by-layer nanoparticle for systemic targeting of KRAS/P53 with cisplatin to treat non–small cell lung cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-2186
  contributor:
    fullname: Gu
– volume: 128
  start-page: 235
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0270
  article-title: Development of PLGA dry powder microparticles by supercritical CO2-assisted spray-drying for potential vaccine delivery to the lungs
  publication-title: J. Supercrit. Fluids
  doi: 10.1016/j.supflu.2017.06.004
  contributor:
    fullname: Tavares
– volume: 5
  start-page: 103380
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0300
  article-title: A pH sensitive co-delivery system of siRNA and doxorubicin for pulmonary administration to B16F10 metastatic lung cancer
  publication-title: RSC Adv.
  doi: 10.1039/C5RA21934E
  contributor:
    fullname: Xu
– start-page: 274
  year: 2010
  ident: 10.1016/j.ijpharm.2020.119989_b0080
  article-title: Preparations for Inhalation: Aerodynaminc Assessment of Fine Particles
  publication-title: Eur. Pharm.
  contributor:
    fullname: Council of Europe
– volume: 116
  start-page: 26
  year: 2016
  ident: 10.1016/j.ijpharm.2020.119989_b0030
  article-title: Design of experiments approach on the preparation of dry inhaler chitosan composite formulations by supercritical CO 2 -assisted
  publication-title: J. Supercrit. Fluids
  doi: 10.1016/j.supflu.2016.04.001
  contributor:
    fullname: Cabral
– volume: 1
  start-page: 325
  year: 2005
  ident: 10.1016/j.ijpharm.2020.119989_b0060
  article-title: Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity
  publication-title: Small
  doi: 10.1002/smll.200400093
  contributor:
    fullname: Connor
– volume: 114
  start-page: E10947
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0050
  article-title: Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.1708391114
  contributor:
    fullname: Chung
– volume: 63
  start-page: 885
  year: 2018
  ident: 10.1016/j.ijpharm.2020.119989_b0075
  article-title: Optimization of Supercritical CO 2 -Assisted Atomization: Phase Behavior and Design of Experiments
  publication-title: J. Chem. Eng. Data
  doi: 10.1021/acs.jced.7b00820
  contributor:
    fullname: Costa
– volume: 27
  start-page: 119
  year: 2006
  ident: 10.1016/j.ijpharm.2020.119989_b0140
  article-title: Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2005.05.028
  contributor:
    fullname: Jae
– volume: 455
  start-page: 241
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0240
  article-title: Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2013.07.024
  contributor:
    fullname: Sharma
– ident: 10.1016/j.ijpharm.2020.119989_b0230
  doi: 10.1016/0168-3659(87)90034-4
– volume: 4
  start-page: 1118
  year: 2004
  ident: 10.1016/j.ijpharm.2020.119989_b0335
  article-title: Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers
  publication-title: Macromol. Biosci.
  doi: 10.1002/mabi.200400092
  contributor:
    fullname: Zeng
– year: 2019
  ident: 10.1016/j.ijpharm.2020.119989_b0010
  article-title: Supercritical Fluid Manufacture
  contributor:
    fullname: Aguiar-Ricardo
– volume: 157
  start-page: 383
  year: 2012
  ident: 10.1016/j.ijpharm.2020.119989_b0015
  article-title: Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2011.08.008
  contributor:
    fullname: Al-Qadi
– volume: 53
  start-page: 16
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0190
  article-title: Design of Composite Particles via Spray Drying for DPI Formulations
  publication-title: ONdrugDelivery
  contributor:
    fullname: Moura
– ident: 10.1016/j.ijpharm.2020.119989_b0095
  doi: 10.5772/57235
– volume: 19
  start-page: 900
  year: 2011
  ident: 10.1016/j.ijpharm.2020.119989_b0265
  article-title: Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
  publication-title: J. Drug Target.
  doi: 10.3109/1061186X.2011.622404
  contributor:
    fullname: Taratula
– volume: 364
  start-page: 328
  year: 2008
  ident: 10.1016/j.ijpharm.2020.119989_b0245
  article-title: Mathematical modeling of drug delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2008.09.004
  contributor:
    fullname: Siepmann
– ident: 10.1016/j.ijpharm.2020.119989_b0020
  doi: 10.1016/j.ejpb.2007.05.007
– volume: 530
  start-page: 40
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0045
  article-title: Inhaled powder formulation of naked siRNA using spray drying technology with L-leucine as dispersion enhancer
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.07.013
  contributor:
    fullname: Chow
– volume: 16
  start-page: 2602
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0255
  article-title: Sustainable strategies for nano-in-micro particle engineering for pulmonary delivery
  publication-title: J. Nanoparticle Res.
  doi: 10.1007/s11051-014-2602-0
  contributor:
    fullname: Silva
– volume: 16
  start-page: 18
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0210
  article-title: Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone : Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation
  publication-title: J. Aerosol Med. Pulm. Drug Deliv.
  contributor:
    fullname: Ortiz
– volume: 7
  start-page: 3478
  year: 2014
  ident: 10.1016/j.ijpharm.2020.119989_b0290
  article-title: Recent advances in solid sorbents for CO 2 capture and new development trends
  publication-title: Energy Environ. Sci.
  doi: 10.1039/C4EE01647E
  contributor:
    fullname: Wang
– volume: 34
  start-page: 6853
  year: 2013
  ident: 10.1016/j.ijpharm.2020.119989_b0330
  article-title: IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.05.071
  contributor:
    fullname: Yue
– volume: 26
  start-page: 991
  year: 2016
  ident: 10.1016/j.ijpharm.2020.119989_b0065
  article-title: Highly Scalable, Closed-Loop Synthesis of Drug-Loaded, Layer-by-Layer Nanoparticles
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201504385
  contributor:
    fullname: Correa
– volume: 41
  start-page: 2656
  year: 2012
  ident: 10.1016/j.ijpharm.2020.119989_b0035
  article-title: Nanomedicine themed issue Multifunctional nanoparticles for multimodal imaging and theragnosis w
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C2CS15261D
  contributor:
    fullname: Caruso
– volume: 11
  start-page: 215
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0105
  article-title: Nebulized Gadolinium-Based Nanoparticles: A Theranostic Approach for Lung Tumor Imaging and Radiosensitization
  publication-title: Small
  doi: 10.1002/smll.201401284
  contributor:
    fullname: Dufort
– volume: 20
  start-page: 33
  year: 2010
  ident: 10.1016/j.ijpharm.2020.119989_b0125
  article-title: The potential of chitosan for pulmonary drug delivery
  publication-title: J. Drug Deliv. Sci. Technol.
  doi: 10.1016/S1773-2247(10)50004-2
  contributor:
    fullname: Grenha
– volume: 28
  start-page: 1
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0215
  article-title: Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler
  publication-title: J. Aerosol Med. Pulm. Drug Deliv.
  contributor:
    fullname: Pai
– volume: 6
  start-page: 1239
  year: 2015
  ident: 10.1016/j.ijpharm.2020.119989_b0120
  article-title: The advantages of pulmonary delivery of therapeutic siRNA
  publication-title: Ther. Deliv.
  doi: 10.4155/tde.15.8
  contributor:
    fullname: Feldmann
– volume: 24
  start-page: 745
  year: 2017
  ident: 10.1016/j.ijpharm.2020.119989_b0220
  article-title: Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting Preparation and testing of cefquinome-loaded poly lactic-co-glycolic
  publication-title: Drug Deliv.
  doi: 10.1080/10717544.2017.1321058
  contributor:
    fullname: Qu
– volume: 17
  start-page: 156
  year: 2018
  ident: 10.1016/j.ijpharm.2020.119989_b0185
  article-title: Alnylam prepares to land first RNAi drug approval
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2018.20
  contributor:
    fullname: Morrison
– volume: 8
  start-page: 7240
  year: 2016
  ident: 10.1016/j.ijpharm.2020.119989_b0165
  article-title: Breakable mesoporous silica nanoparticles for targeted drug delivery
  publication-title: Nanoscale
  doi: 10.1039/C5NR09112H
  contributor:
    fullname: Maggini
– volume: 25
  start-page: 999
  year: 2008
  ident: 10.1016/j.ijpharm.2020.119989_b0285
  article-title: Pharmaceutical particle engineering via spray drying
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-007-9475-1
  contributor:
    fullname: Vehring
– volume: 10
  start-page: 993
  year: 2009
  ident: 10.1016/j.ijpharm.2020.119989_b0195
  article-title: Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study
  publication-title: AAPS PharmSciTech
  doi: 10.1208/s12249-009-9290-6
  contributor:
    fullname: Naikwade
SSID ssj0006213
Score 2.448799
Snippet [Display omitted] •siRNA nanovehicles were micronized using supercritical CO2-assisted spray drying.•The siRNA integrity was preserved through the...
Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 119989
SubjectTerms Layer-by-layer nanoparticles
Micronized systems
Pulmonary delivery
Small interfering RNAs
Supercritical carbon dioxide
Title Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy
URI https://dx.doi.org/10.1016/j.ijpharm.2020.119989
https://www.ncbi.nlm.nih.gov/pubmed/33122113
https://search.proquest.com/docview/2456411104
https://pubmed.ncbi.nlm.nih.gov/PMC7970503
Volume 591
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6VcuGCdlkeZVnklRAn0qZ2EjfHqgJ1d0VV8ZCQOFhx7UArlFalXamX_e3MJE5LQQhpj7GTyPGMxzOZbz4DnIh0wGUrSrwwiiMvsFZ4sZWJJ8NAB74xqYipUPiyF3Vvg9934V0FOmUtDMEqne0vbHpurV1Lw81mYzIcNq59kR8sLzhlCSQVr2_idkS52s32rz_d3tIgR9ydkowBEz2wKuRpjOrD0YQ4ojFS5GQ_MPqIP9qi3rugb5GUr7amiy-w7XxK1i6G_RUqNtuB035BSr04YzerGqvnM3bK-iu66sU3uL9y_wOZydEcbJyyHGaIfuODZWY6f8CeJ8JvLNhf-5jj6Bj6umwyf0IlTrD5qtdmRDwxddWDrCjrWuzC7cX5TafruSMXvAFazJmHwUzaSgwu0pyJLxYClygx9iQispLbOGj6mlgCmyn3A2mMNr4JuaTkpOWDUOxBNRtn9gCYxViFa5kGA4HvFqEW2tdamyixErv8GtTLWVaTgllDlZCzkXJiUSQWVYilBq1SFmpNRRRa_88e_VnKTuHyoZxIktnx_FlR3heVBoPSGuwXslyOBr-dY3wsaiDXpLy8gai513uy4WNO0S1jSUQ7h_8_5O-wRVeEnGmGR1CdTef2B_o_M30MG_V_zWOn5S9cRwa6
link.rule.ids 230,314,780,784,885,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4h9rC9IMb4URjMkxBPpE1tJ24eEQIVBhViRULagxXXTmmF0qq0k_qyv313iUPXIYTEq-1Eju98vst99xngUGQ9rlpxGkRxEgfSOREkTqWBiqSRobWZSKhQ-LoTt-_k5X10vwKnVS0MwSq97S9temGtfUvDr2ZjPBg0foaiuFhecMoSKCpe_yAj9H5Rqet_FjiPmPs7kjFcouGLMp7GsD4YjokhGuNETtYDY4_ktQPqpQP6P47yn4PpfB3WvEfJTspJf4YVl2_A0U1JST0_Zt1FhdXTMTtiNwuy6vkX-HXr_wYyW2A52ChjBcgQvca-Y3Yy62PPI6E35uy3eyhQdAw9XTaePaIKp9h82zlhRDsx8bWDrCzqmm_C3flZ97Qd-AsXgh7ay2mAoUzWSi1u0YKHLxECNyjx9aQidoq7RDZDQxyBzYyHUllrbGgjrig16XgvEluwmo9ytwPMYaTCjcpkT-C7RWSECY0xNk6dwq6wBvVqlfW45NXQFeBsqL1YNIlFl2KpQauShV5SEI22_61Hv1ey07h5KCOS5m40e9KU9ZVo7UNZg-1Sls-zwW_nGB2LGqglKT8PIGLu5Z588FAQdKtEEc3O7vun_A0-trvXV_rqovNjDz5RD2FomtFXWJ1OZm4fPaGpOSg0_S_ELweT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rational+design+of+multistage+drug+delivery+vehicles+for+pulmonary+RNA+interference+therapy&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Silva%2C+A.+Sofia&rft.au=Shopsowitz%2C+Kevin+E.&rft.au=Correa%2C+Santiago&rft.au=Morton%2C+Stephen+W.&rft.date=2020-12-15&rft.pub=Elsevier+B.V&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=591&rft_id=info:doi/10.1016%2Fj.ijpharm.2020.119989&rft.externalDocID=S0378517320309741
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon